Colonic Propionate, Appetite, and Weight Loss (NCT03322514) | Clinical Trial Compass
CompletedNot Applicable
Colonic Propionate, Appetite, and Weight Loss
United Kingdom12 participantsStarted 2017-03-29
Plain-language summary
The current protocol aims to investigate the impact of the propionate ester in conjugation with restricted diet on appetite and weight loss.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* overweight or obese ((BMI) of 25-35 kg/m2)
* healthy
* aged between 18 and 65 years
Exclusion Criteria:
* Weight change of ≥ 3kg in the preceding 2 months
* Undergone any weight loss surgery or gastric procedures to promote weight loss
* Current smokers
* Substance abuse
* Excess alcohol intake
* Pregnancy
* Diabetes
* Cardiovascular disease
* Cancer
* Gastrointestinal disease e.g. inflammatory bowel disease or irritable bowel syndrome
* Kidney disease
* Liver disease
* Pancreatitis
* Use of medications likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti-inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.
Any participants with the above conditions would already have an altered pattern of hormones and inflammatory molecules because of their disease process and would therefore give us confounding or misleading results.